Cargando…

Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma

IMPORTANCE: Because of tumor heterogeneity, traditional clinical variables remain insufficient to predict recurrence, which impairs long-term survival among patients undergoing radical hepatectomy for hepatocellular carcinoma (HCC). Vessels encapsulating tumor clusters (VETC) constitute a novel vasc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wen-Ping, Xing, Kai-Li, Fu, Jian-Chang, Ling, Yi-Hong, Li, Shao-Hua, Yu, Wu-Shen, Zhang, Yong-Fa, Zhong, Chong, Wang, Jia-Hong, Chen, Zhi-Yuan, Lu, Liang-He, Wei, Wei, Guo, Rong-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438596/ https://www.ncbi.nlm.nih.gov/pubmed/34515782 http://dx.doi.org/10.1001/jamanetworkopen.2021.25055

Ejemplares similares

Anatomical versus Non-anatomical Resection for Hepatocellular Carcinoma with Microscope Vascular Invasion: A Propensity Score Matching Analysis
por: Zhong, Xiao-Ping, et al.
Publicado: (2019)

Silencing of Mutator Elements in Maize Involves Distinct Populations of Small RNAs and Distinct Patterns of DNA Methylation
por: Burgess, Diane, et al.
Publicado: (2020)

A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection
por: XIAO, CHENG-ZUO, et al.
Publicado: (2015)

Distinct requirements for Pho, Sfmbt, and Ino80 for cell survival in Drosophila
por: Elizarev, Pavel, et al.
Publicado: (2021)

Cezanne predicts progression and adjuvant TACE response in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2017)

Dovitinib preferentially targets endothelial cells rather than cancer cells for the inhibition of hepatocellular carcinoma growth and metastasis
por: Chen, Zhi-Yuan, et al.
Publicado: (2012)

Decreased Cezanne expression is associated with the progression and poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus
por: Li, Wei-Ping, et al.
Publicado: (2017)

Development and validation of a nomogram for assessing survival in patients with hepatocellular carcinoma after hepatectomy
por: Huo, Rong-Rui, et al.
Publicado: (2020)

Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
por: Ling, Yi-hong, et al.
Publicado: (2020)

Transarterial chemoembolization combined with sorafenib for the treatment of hepatocellular carcinoma with hepatic vein tumor thrombus
por: Zhang, Yong-Fa, et al.
Publicado: (2016)

Resection vs. Sorafenib for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Real World, Propensity Score Matched Analytic Study
por: Mei, Jie, et al.
Publicado: (2020)

The relationship between serum hypoxia-inducible factor 1α and coronary artery calcification in asymptomatic type 2 diabetic patients
por: Li, Gang, et al.
Publicado: (2014)

The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE
por: Lu, Liang-He, et al.
Publicado: (2021)

The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early‐stage hepatocellular carcinoma
por: Chen, Zhi‐Yuan, et al.
Publicado: (2021)

Correlation of Milestone Restricted Mean Survival Time Ratio With Overall Survival Hazard Ratio in Randomized Clinical Trials of Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis
por: Wang, Zi-Xian, et al.
Publicado: (2019)

Elevated expression of Cripto-1 correlates with poor prognosis in hepatocellular carcinoma
por: Wang, Jia-hong, et al.
Publicado: (2015)

Updating the Know Your Chances Website to Include Smoking Status as a Risk Factor for Mortality Estimates
por: Woloshin, Steven, et al.
Publicado: (2023)

Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
por: Wei, Wei, et al.
Publicado: (2018)

Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
por: Lu, Liang‐He, et al.
Publicado: (2020)

NCKAP1 improves patient outcome and inhibits cell growth by enhancing Rb1/p53 activation in hepatocellular carcinoma
por: Zhong, Xiao-ping, et al.
Publicado: (2019)

Association of Sustained Response Duration With Survival After Conventional Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma
por: Zhang, Yaojun, et al.
Publicado: (2018)

Global trend of diabetes mortality attributed to vascular complications, 2000–2016
por: Ling, Wei, et al.
Publicado: (2020)

Development and Validation of Novel Models Including Tumor Micronecrosis for Predicting the Postoperative Survival of Patients with Hepatocellular Carcinoma
por: Sun, Xuqi, et al.
Publicado: (2023)

Association of Hepatitis B Virus DNA Level and Follow-up Interval With Hepatocellular Carcinoma Recurrence
por: Wang, Wei, et al.
Publicado: (2020)

Development and Validation of a Nomogram for Assessing Survival in Patients With Metastatic Lung Cancer Referred for Radiotherapy for Bone Metastases
por: Yap, Wing-Keen, et al.
Publicado: (2018)

Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for carotid atherosclerosis in hospital-based patients with type 2 diabetes: a cross-sectional study
por: Li, Lian-Xi, et al.
Publicado: (2015)

Genetic Diversity and Population Structure of Chinese Foxtail Millet [Setaria italica (L.) Beauv.] Landraces
por: Wang, Chunfang, et al.
Publicado: (2012)

Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma
por: Zhou, Shao-Lai, et al.
Publicado: (2021)

Phylogenetic Reclassification of Vertebrate Melatonin Receptors To Include Mel1d
por: Denker, Elsa, et al.
Publicado: (2019)

Validation of Progression-Free Survival Rate at 6 Months and Objective Response for Estimating Overall Survival in Immune Checkpoint Inhibitor Trials: A Systematic Review and Meta-analysis
por: Kok, Peey-Sei, et al.
Publicado: (2020)

Progression of Vascular Calcification and Clinical Outcomes in Patients Receiving Maintenance Dialysis
por: Zhang, Haitao, et al.
Publicado: (2023)

Reason of Discontinuation After Transarterial Chemoembolization Influences Survival in Patients with Hepatocellular Carcinoma
por: Labeur, Tim A., et al.
Publicado: (2018)

Comparison of Survival and Patterns of Recurrence in Gastric Neuroendocrine Carcinoma, Mixed Adenoneuroendocrine Carcinoma, and Adenocarcinoma
por: Lin, Jianxian, et al.
Publicado: (2021)

Optimal surgical strategy for hepatocellular carcinoma with portal vein tumor thrombus: A propensity score analysis
por: Zhang, Yong-Fa, et al.
Publicado: (2016)

Nomograms to estimate long-term overall survival and breast cancer-specific survival of patients with luminal breast cancer
por: Sun, Wei, et al.
Publicado: (2016)

Distinct effects of glucose and glucosamine on vascular endothelial and smooth muscle cells: Evidence for a protective role for glucosamine in atherosclerosis
por: Duan, Wenlan, et al.
Publicado: (2005)

Novel Value of Preoperative Gamma-Glutamyltransferase Levels in the Prognosis of AFP-Negative Hepatocellular Carcinoma
por: Lu, Liang-He, et al.
Publicado: (2020)

ELTD1 Function in Hepatocellular Carcinoma is Carcinoma-Associated Fibroblast-Dependent
por: Kan, Anna, et al.
Publicado: (2018)

Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma: A Meta-analysis Including Low PD-L1 Subgroups
por: Yap, Dominic Wei Ting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qg52riv03r49venpili1uk25ug